hrp0086p1-p748 | Pituitary and Neuroendocrinology P1 | ESPE2016
Bounaga Amina
, Schillo Frank
, Mignot Brigitte
, Toussirot Eric
, Borot Sophie
, Bertrand Anne Marie
Background: GH treatment in severe GH deficiency during the transition period is a key matter.Objective and hypotheses: To assess the outcome of 30 severe GH deficient (GHD) patients after a structured transition program, in a French Universitary Hospital between 1988 and 2014.Method: 30 patients treated with GH until final height for congenital deficiency: 16/30 (12 ectopic posterior pituitary), brain tumors: 11/30 (5 RathkeÂ’...